Featured
-
-
Molecular Diagnostics
| Open AccessIdentification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics
- W Wang
- , H-L Jia
- & S-Z Yao
-
Molecular Diagnostics
| Open AccessLeptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration
- Z Dong
- , S Fu
- & C Wang
-
Clinical Study
| Open AccessLow-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients
- C Posch
- , F Weihsengruber
- & K Rappersberger
-
Molecular Diagnostics
| Open AccessProstate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction
- G T Lee
- , D I Kang
- & I Y Kim
-
Molecular Diagnostics
| Open AccessElevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
- M J M Gooden
- , V R Wiersma
- & E Bremer
-
Molecular Diagnostics
| Open AccessEIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo
- J-H Wei
- , J-Z Cao
- & J-H Luo
-
Molecular Diagnostics
| Open AccessGalectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
- N M A White
- , O Masui
- & G M Yousef
-
Clinical Study
| Open AccessA nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy
- J Li
- , Y Liu
- & F Shen
-
Molecular Diagnostics
| Open AccessAntitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer
- Q Yang
- , F Zhang
- & C Chen
-
Epidemiology
| Open AccessTime-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics
- E Colzani
- , A L V Johansson
- & K Czene
-
Molecular Diagnostics
| Open AccessTMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
- L Larzabal
- , A L de Aberasturi
- & A Calvo
-
Translational Therapeutics
| Open AccessCD44 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells’ metastasis via the regulation of ERK1/2
- G Chang
- , J Wang
- & T Pang
-
Molecular Diagnostics
| Open AccessCirculating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis
- C Chen
- , C A Duckworth
- & L-G Yu
-
Letter to the Editor
| Open AccessIntra-patient heterogeneity of BRAF mutation status: fact or fiction?
- A M Menzies
- , J S Wilmott
- & R A Scolyer
-
Molecular Diagnostics
| Open AccessIntratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
- I Zlobec
- , M Hädrich
- & A Lugli
-
Molecular Diagnostics
| Open AccessRole of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment
- Y H Park
- , H A Jung
- & Y-H Im
-
Molecular Diagnostics
| Open AccessAkt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma
- Y Wang
- , Z Lin
- & W Chen
-
Molecular Diagnostics
| Open AccessPredictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis
- J Lu
- , X Xu
- & X Li
-
Molecular Diagnostics
| Open AccessBrain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression
- L Wyler
- , C U Napoli
- & H Moch
-
Molecular Diagnostics
| Open Accessc-FOS suppresses ovarian cancer progression by changing adhesion
- L Oliveira-Ferrer
- , K Rößler
- & K Milde-Langosch
-
Molecular Diagnostics
| Open AccessCD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma
- H Okabe
- , T Ishimoto
- & H Baba
-
Molecular Diagnostics
| Open AccessTumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases
- C Kahlert
- , M Pecqueux
- & M Koch
-
Molecular Diagnostics
| Open AccessMicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4
- W Tang
- , Y Zhu
- & L Cui
-
Clinical Study
| Open AccessPreoperative nomogram for the identification of lymph node metastasis in early cervical cancer
- D-Y Kim
- , S-H Shim
- & J-H Nam
-
Molecular Diagnostics
| Open AccessPancreatic stellate cells promote hapto-migration of cancer cells through collagen I-mediated signalling pathway
- J Lu
- , S Zhou
- & M G Bachem
-
Molecular Diagnostics
| Open AccessMutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
- L Heinzerling
- , M Baiter
- & R Schneider-Stock
-
Translational Therapeutics
| Open AccessHuman fucosyltransferase 6 enables prostate cancer metastasis to bone
- J Li
- , A D Guillebon
- & M R King
-
Clinical Study
| Open AccessPhase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)
- S Nicholson
- , E Hall
- & A Bahl
-
Molecular Diagnostics
| Open AccessDirect targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis
- F Peng
- , J Jiang
- & R Qin
-
Reply to Letter to the Editor
| Open AccessReply: Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab’
- M Schirripa
- , F Loupakis
- & A Falcone
-
Letter to the Editor
| Open AccessComment on ‘Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab’
- F Bibeau
- , H Gil
- & F Boissière-Michot
-
Clinical Study
| Open AccessThe EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients
- P Dubsky
- , J C Brase
- & M Filipits
-
Molecular Diagnostics
| Open AccessCXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
- D Bedognetti
- , T L Spivey
- & F M Marincola
-
Molecular Diagnostics
| Open AccessAurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
- J A C M Goos
- , V M H Coupe
- & R J A Fijneman
-
Molecular Diagnostics
| Open AccessTumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma
- T Kinoshita
- , N Nohata
- & N Seki
-
Molecular Diagnostics
| Open AccessLysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis
- T Osawa
- , N Ohga
- & K Hida
-
Translational Therapeutics
| Open AccessCXCR7-mediated progression of osteosarcoma in the lungs
- E Goguet-Surmenian
- , P Richard-Fiardo
- & H Schmid-Antomarchi
-
Clinical Study
| Open Access‘Being there’ for women with metastatic breast cancer: a pan-European patient survey
- V Harding
- , M Afshar
- & J Stebbing
-
Molecular Diagnostics
| Open AccessMolecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay
- T Osako
- , H Tsuda
- & S Nakamura
-
Molecular Diagnostics
| Open AccessMaspin is a marker for early recurrence in primary stage III and IV colorectal cancer
- N Snoeren
- , B L Emmink
- & I H M Borel Rinkes
-
Molecular Diagnostics
| Open AccessPre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases
- G Bouchard
- , G Bouvette
- & B Paquette
-
Molecular Diagnostics
| Open AccessTNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer
- T Liu
- , H Gao
- & H Yin
-
Molecular Diagnostics
| Open AccessP2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells
- W-H Li
- , Y Qiu
- & W-G Fang
-
Molecular Diagnostics
| Open AccessDigital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype
- H K Angell
- , N Gray
- & M Cumberbatch
-
Clinical Study
| Open AccessS-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis
- S Y Kim
- , Y S Hong
- & K H Jung
-
Clinical Study
| Open AccessSupport vector machine-based nomogram predicts postoperative distant metastasis for patients with oesophageal squamous cell carcinoma
- H X Yang
- , W Feng
- & J H Fu
-
Clinical Study
| Open AccessRibosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma
- L Fan
- , P Li
- & Z Wang
-
Clinical Study
| Open AccessA phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
- P A Cassier
- , A Lefranc
- & J-Y Blay
-
Translational Therapeutics
| Open AccessSrc kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
- J G van Oosterwijk
- , M A J H van Ruler
- & J V M G Bovée